Ushering in the next generation of precision trials for pediatric cancer

We describe an emerging regulatory framework that is accelerating the pace of clinical trials in children as well as design challenges that are specific to trials that involve young cancer patients. Last, we discuss new drug development approaches for pediatric cancers whose growth relies on proteins that are difficult to target therapeutically, such as transcription factors.
Source: ScienceNOW - Category: Science Authors: Tags: Medicine, Diseases special/review Source Type: news